The 20 Best Large-Cell Lung Carcinoma Doctors near Dallas, TX

. Dr. Soriano is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Lung Metastases, and Gastrostomy.

Dr. Konduri attended medical school at the University College of Medical Sciences-India. He then completed a residency in Internal Medicine at Rush Presbyterian St Luke's - Westlake Residency Program, Melrose Park, Illinois, followed by a fellowship in Medical Oncology at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Konduri is certified in Internal Medicine and in Medical Oncology by the American Board of Internal Medicine. He specializes in medical oncology with a particular interest in lung and thoracic oncology. Dr. Konduri is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.

Jonathan Dowell is a Hematologist in Dallas, Texas. Dr. Dowell is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and EGFR Positive Lung Cancer.

Sawsan Rashdan is a Hematologist in Dallas, Texas. Dr. Rashdan is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma.

David Gerber is an Oncologist in Dallas, Texas. Dr. Gerber is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Endoscopy.

Randall Hughes is an Oncologist in Dallas, Texas. Dr. Hughes is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Endoscopy.

Sheena Bhalla is a Hematologist in Dallas, Texas. Dr. Bhalla is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Squamous Cell Lung Carcinoma.

Gautam Baskaran is an Intensive Care Medicine provider in Dallas, Texas. Dr. Baskaran is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Cerebral Hypoxia, Pneumonia, and Gastrostomy.

Dr. Nadler specializes in medical oncology. He serves as a Medical Director of US Oncology Health Informatics and Internet Technology. He remains active in USON research committees in lung cancer, head and neck cancer, and sarcoma within the developmental committees. Dr. Nadler received a BA with highest honors from Wesleyan University double majoring in molecular biology and philosophy. He received his joint MD/MPP from Harvard Medical School and a Master in Public Policy from Harvard University's Kennedy School of Government. Dr. Nadler then completed his internship and residency in Boston, MA, at Brigham and Women's Hospital in Boston and his oncology fellowship at Dana Farber Cancer Institute/MGH. Dr. Nadler is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Adenoid Cystic Carcinoma, Bone Tumor, and Pleuropulmonary Blastoma.

Dr. Kummerfeldt specializes in pulmonary and critical care medicine. He is experienced the treatment of general pulmonary conditions such as pleural effusions, asthma, COPD, pulmonary nodules, cough and interstitial lung disease. He has a professional interest in pleural disease, thoracic and critical care ultrasound. Dr. Kummerfeldt is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Lung Nodules, Advanced Bronchoscopy, and Gastrostomy.

Sudheer Nambiar is an Internal Medicine specialist and an Intensive Care Medicine provider in Dallas, Texas. Dr. Nambiar is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Pneumonia, Hospital-Acquired Pneumonia, Atypical Pneumonia, Gastrostomy, and Awake Craniotomy.

Steven Wu is an Intensive Care Medicine provider in Dallas, Texas. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Nodules, Lymphofollicular Hyperplasia, Interstitial Lung Disease, and Acute Interstitial Pneumonia.

Audra Schwalk is an Intensive Care Medicine provider in Dallas, Texas. Dr. Schwalk is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Nodules, Sarcoidosis, Interstitial Lung Disease, Advanced Bronchoscopy, and Endoscopy.

Meron Weldeab is an Internal Medicine provider in Dallas, Texas. Dr. Weldeab is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Metastatic Brain Tumor, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Gastrostomy, and Gamma Knife Radiosurgery.

Corey Kershaw is an Intensive Care Medicine provider in Dallas, Texas. Dr. Kershaw is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pneumonia, Lung Transplant, and Gastrostomy.

Traci Adams is an Intensive Care Medicine provider in Dallas, Texas. Dr. Adams is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Hypersensitivity Pneumonitis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Endoscopy, and Lung Transplant.

Hetal Patel is an Intensive Care Medicine provider in Dallas, Texas. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Metastases, Interstitial Lung Disease, Acute Interstitial Pneumonia, Advanced Bronchoscopy, and Gastrostomy.

Robert Mennel is an Internal Medicine specialist and an Oncologist in Dallas, Texas. Dr. Mennel is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Angiosarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma of the Scalp, and Mesenchymoma.

Dr. Kelly received his medical degree from the Royal College of Surgeons in Ireland in 1998. He completed his internship, residency and oncology fellowship from the Royal College of Physicians in Ireland in 2007. Dr. Kelly completed a second fellowship in medical oncology at the National Cancer Institute (NCI) in Bethesda MD from 2007–2009 and continued as a clinical researcher in thoracic oncology at the NCI until moving to Johns Hopkins in 2011. At Johns Hopkins, Dr. Kelly was the director of the gastroesophageal cancer therapeutics program and also served as the director of global oncology for Johns Hopkins International. Dr. Kelly was recruited as the Director of Oncology for the Charles A. Sammons Cancer Center and the Chief of Oncology for the North Texas Division of the BSWH system in 2018. Dr. Kelly performs translational and clinical research encompassing the discovery and the development of new targeted and immunotherapeutic approaches in the prevention and treatment of gastroesophageal cancer and lung cancer and he is the International principal investigator on a number of global phase II/III clinical trials in these disease areas. In addition he is leading efforts nationally and internationally to design quality metrics for solid tumors and implementing value-based algorithms to help bend the cost curve in the United States. At the Charles A. Sammons Cancer Center he also helps to co-lead the Innovative Clinical Trials Center which investigates novel therapeutics across a range of tumor types. He serves as the co-chair of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO) taskforce working to improve the quality of care received by lung cancer patients worldwide. He is an active member of ASCO and the Eastern Cooperative Oncology group. He is a founding member of the International Quality Oncology Taskforce in ASCO and serves on the ASCO measures taskforce, the clinical practice committee and the lung cancer quality taskforce. He has authored and co-authored over 150 peer-reviewed publications, abstracts and book chapters, and contributed his work to many prominent healthcare journals. Dr. Kelly’s leadership of oncology services spans Baylor Scott & White’s footprint in the Dallas-Fort Worth area, which includes Baylor University Medical Center—the System’s North Texas flagship hospital and one of the largest cancer hospitals in the nation—as well as a network of 11 Baylor Charles A. Sammons Cancer Centers throughout Texas. Publications. Dr. Kelly is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Esophageal Cancer, Gastroesophageal Junction Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreaticoduodenectomy, and Tissue Biopsy.

"""Dr. Denham specializes in Hematology and Medical Oncology. He is board certified in Medical Oncology and Internal Medicine. Dr. Denham is a Diplomate of the American Board of Internal Medicine with subspecialty certification in Medical Oncology.""". Dr. Denham is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Bone Tumor, Mesothelioma, and Thymectomy.